Excessive stress during old age could lead to decline of cognitive function and can lead on onset of Alzheimer’s disease, according to a research conducted at the Albert Einstein College of Medicine and Montefiore Health System. During old age, many people suffer from memory issues, lack of attentiveness and decline in cognitive abilities. The research team found a link between stress during old age and higher incidents of developing aMCI (amnestic mild cognitive impairment).
Offering experimental ‘suicide gene therapy’ along with chemotherapy has yielded positive results for prostate cancer patients in a study conducted at the Houston Methodist Hospital in Texas. The suicide gene therapy works by triggering immune system to kill prostate cancer cells. The research team manipulated some of the cancer cells by introducing herpes virus and the body’s immune system killed the cancer cells.
Chipotle Mexican Grill has been in the news for E. Coli and Norovirus outbreaks in several states over the past few weeks. The issues with Chipotle restaurants started in July this year when the first case of infection linked to food served at Chipotle surfaced. The company has taken a few steps to ensure safety of customers. However, in the wake of new incidents of infections, Chipotle could face further scrutiny. After the restaurant chain has been on the receiving end for the last few weeks due to E.
High-stress, which has already been blamed of causing numerous health problems from depression to high blood pressure, has now been charged on causing Alzheimer’s disease. According to scientists at Albert Einstein College of Medicine and Montefiore Health System, people with mild cognitive impairment (MCI) are at increased risk of developing Alzheimer’s disease. Researchers said there is huge link between high stress and type of memory decline that is often as a prelude of Alzheimer’s disease. They added that people with high stress are more likely to develop MCI and so the disease.
You must have heard of Martin Shkreli, who was in highlights earlier this year for widely increasing the prices of a 62-year-old drug for toxoplasmosis from $13.50 to $750 per pill. Shkreli recently announced that he will increase the price of the decades-old drug for a serious infectious disease, the Chagas disease, a parasitic infection known to cause lethal heart problems. The 32-year old former hedge fund manager has again provoked alarm among Chagas community and some organizations that supply drugs for neglected diseases.
Antibiotic resistance reached to a new level when a new strain of E.coli was found that was impervious to the last line of defence medication and also has the ability to infect other bacteria. First time, it was found in China.
The strain was identified in a pig then it raw pork meat and then in a small number of people. The strain has been found in Germany, in a Danish man and also in Malaysia. Scientists have found that the strain to be carrying a gene known as mcr-1 and this gene makes it different from other E.coli. The gene could be the power house of the strain.
In a long term research conducted at the Houston Methodist Hospital, researchers have found effective results using a combination of ‘Suicide Gene Therapy’ and chemotherapy. The team registered over 90 percent success rate in treatment of prostate cancer by triggering body’s immune system response. By introducing a modification in few cancer cells, the medical research team at Houston Methodist Hospital was able to achieve good results for patients suffering from prostate cancer.
Nothing is going in favor of restaurant chain Chipotle Mexican Grill. Illness cases linked to E. coli outbreak are rising, shares of the company are dropping and people are avoiding its restaurants. Now, Boston College announced on Monday that over 20 of its students, including eight of its men’s basketball players, have fallen sick after eating at a Chipotle restaurant.
It is not known whether the Boston College illness cases are linked to E. coli outbreak of Denver-headquartered restaurant chain that has sickened more than 50 individuals in nine US states.
The Food and Drug Administration (FDA) on Friday gave its approval to an experimental drug by Genentech meant for patients with a particular type of lung cancer that has very few treatment options.
The company announced that Alecensa won FDA’s approval for the use in patients with advance non-small lung cancer. Patients with this lung cancer have a mutation in a gene called ALK.